Correction: Diagnostic and Prognostic Utilities of Humoral Fibulin-3 in Malignant Pleural Mesothelioma: Evidence from a Meta-Analysis

Dongxu Pei,Yongwei Li,Xinwei Li,Sha Yan,Xiaolan Guo,Xianglian Xu,Xiaoxia Guo

DOI: https://doi.org/10.18632/oncotarget.25301

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14712.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.

Fenming Zhang,Chengfu Xu,Longgui Ning,Fengling Hu,Guodong Shan,Hongtan Chen,Ming Yang,Wenguo Chen,Jiekai Yu,Guoqiang Xu

DOI: https://doi.org/10.1371/journal.pone.0212300

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0167109.].
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum to “Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway” [Heliyon 9(6) (June 2023) e16696]

Xuemeng Qian,Jiajing Cai,Qi Qi,Jia Han,Xinfang Zhu,Rong Xia,Qi Zhang

DOI: https://doi.org/10.1016/j.heliyon.2023.e19952

IF: 3.776

2023-01-01

Heliyon

Abstract:In the original published version of this article, Figure 7b (FIB + AZD of SMMC 7721 cell group) and Figure 7c (FIB of BEL 7404 cell group) was uploaded incorrectly. The correct versions of Figures 7b and c can be found below. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors. Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathwayQian et al.HeliyonMay 25, 2023In BriefHyperfibrinogenemia had been widely observed in various cancer patients, however, whether fibrinogen (FIB) influences the survival outcome of patients with primary liver cancer (PLC) remains unknown. This study was aimed to evaluate the predictive value of preoperative FIB in the survival outcome of PLC patients and explore the possible mechanism. Full-Text PDF Open Access
Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Zhun Wang,Shuanghe Peng,Ning Jiang,Aixiang Wang,Shuguang Liu,Hui Xie,Linpei Guo,Qiliang Cai,Yuanjie Niu

DOI: https://doi.org/10.18632/oncotarget.26394

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.21971.].
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Daling Dong,Shixin Zhang,Bin Jiang,Wei Wei,Chao Wang,Qian Yang,Tingzhi Yan,Min Chen,Liken Zheng,Weikang Shao,Gang Xiong

DOI: https://doi.org/10.3389/fonc.2023.1275851

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1222716.].

oncology
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Haiyang Zhao,Kexin Luo,Meihan Liu,Yuanze Cai,Siman Liu,Shijuan Li,Yongsheng Zhao,Hongpan Zhang

DOI: https://doi.org/10.3389/fgene.2024.1531321

IF: 3.7

2024-12-04

Frontiers in Genetics

Abstract:This article is a correction to: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

genetics & heredity
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Ming Cui,Lei You,Bang Zheng,Xinmei Huang,Qiaofei Liu,Jing Huang,Boju Pan,Xiaoyan Qiu,Quan Liao,Yupei Zhao

DOI: https://doi.org/10.7150/jca.32930

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.39800.].
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Usefulness of Plasma D-dimer Level for Monitoring Development of Distant Organ Metastasis in Colorectal Cancer Patients after Curative Resection [Corrigendum]

Yi Guo,Feng Chen,Wei Cui

DOI: https://doi.org/10.2147/cmar.s194759

2018-01-01

Cancer Management and Research

Abstract:[This corrects the article on p. 4203 in vol. 10, PMID: 30323676.].
Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis

Lingxiao Qiu,Pan Song,Pingmei Chen,Huaqi Wang,Fangfang Li,Mengxuan Shu,Gen-cheng Gong,Xiangjin Song,Chun Huang,Hongxia Jia,Nana Li

DOI: https://doi.org/10.3389/fonc.2024.1486678

IF: 4.7

2024-09-14

Frontiers in Oncology

Abstract:This article is a correction to: Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis

oncology
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Lin Lu,Deling Wang,Lili Wang,Linning E,Pingzhen Guo,Zhiming Li,Jin Xiang,Hao Yang,Hui Li,Shaohan Yin,Lawrence H. Schwartz,Chuanmiao Xie,Binsheng Zhao

DOI: https://doi.org/10.1007/s00330-020-07036-9

IF: 7.034

2020-07-22

European Radiology

Abstract:The original version of this article, published on 21 February 2020, unfortunately contained a mistake.

radiology, nuclear medicine & medical imaging
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology

Correction: Diagnostic and Prognostic Utilities of Humoral Fibulin-3 in Malignant Pleural Mesothelioma: Evidence from a Meta-Analysis

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum to “Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway” [Heliyon 9(6) (June 2023) e16696]

Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Usefulness of Plasma D-dimer Level for Monitoring Development of Distant Organ Metastasis in Colorectal Cancer Patients after Curative Resection [Corrigendum]

Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer